Navigation überspringen
Universitätsbibliothek Heidelberg
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Heyse, Miriam [VerfasserIn]   i
 Schneider, Christine [VerfasserIn]   i
 Drüschler, Katharina [VerfasserIn]   i
 Berberich, Anne [VerfasserIn]   i
 Zorn, Markus [VerfasserIn]   i
 Ringleb, Peter A. [VerfasserIn]   i
 Okun, Jürgen G. [VerfasserIn]   i
 Mundiyanapurath, Sibu [VerfasserIn]   i
Titel:Trimethylamine-N-Oxide levels are similar in asymptomatic vs. symptomatic cerebrovascular atherosclerosis
Verf.angabe:Miriam Heyse, Christine Schneider, Peter Monostori, Kathrin V. Schwarz, Jana Hauke, Katharina Drüschler, Anne Berberich, Markus Zorn, Peter A. Ringleb, Jürgen G. Okun and Sibu Mundiyanapurath
E-Jahr:2021
Jahr:19 March 2021
Umfang:6 S.
Teil:volume:12
 year:2021
 month:03
 elocationid:617944
 extent:6
Fussnoten:Gesehen am 04.05.2021
Titel Quelle:Enthalten in: Frontiers in neurology
Ort Quelle:Lausanne : Frontiers Research Foundation, 2008
Jahr Quelle:2021
Band/Heft Quelle:12(2021) vom: März, Artikel-ID 617944
ISSN Quelle:1664-2295
Abstract:Abstract: Introduction: Trimethylamine-N-oxide (TMAO) is correlated with atherosclerosis and vascular diseases as coronary heart disease and ischemic stroke. The aim of the study was investigate whether TMAO levels are different in symptomatic vs. asymptomatic cerebrovascular atherosclerosis. Methods: This was a prospective, case-control study, conducted at a tertiary care university hospital. Patients were included if they had large-artery atherosclerosis (TOAST criteria). Symptomatic patients with ischemic stroke were compared with asymptomatic patients. As primary endpoint, TMAO levels on admission were compared between symptomatic and asymptomatic patients. Univariable analysis was performed using Mann-Whitney-U test and multivariable analysis using binary logistic regression. TMAO values were adjusted for glomerular filtration rate (GFR), age and smoking. Results: Between 2018 and 2020, 82 symptomatic and asymptomatic patients were recruited. Median age was 70 years, 65% were male. Comparing symptomatic (n=42) and asymptomatic (n=40) patients, no significant differences were found in univariable analysis in TMAO (3.96 [IQR 2.30-6.73] vs. 5.36 [3.59-8.68] μmol/l; p=0.055), GFR (87 [72-97] vs. 82 [71-90] ml/min*1.73m2; p=0.189) and age (71 [60-79] vs. 69 [67-75] years; p=0.756). In multivariable analysis TMAO was not a predictor of symptomatic cerebrovascular disease after adjusting for age and GFR (OR 1.003 [95% CI: 0.941-1.070]; p=0.920). In a sensitivity analysis, we only analyzed patients with symptomatic stenosis and excluded patients with occlusion of brain-supplying arteries. Again, TMAO was not a significant predictor of symptomatic stenosis (OR 1.039 [0.965-1.120], p=0.311). Conclusion: TMAO levels could not be used to differentiate between symptomatic and asymptomatic cerebrovascular disease in our study.
DOI:doi:10.3389/fneur.2021.617944
URL:Kostenfrei: Volltext ; Verlag: https://doi.org/10.3389/fneur.2021.617944
 Kostenfrei: Volltext: https://www.frontiersin.org/articles/10.3389/fneur.2021.617944/full
 DOI: https://doi.org/10.3389/fneur.2021.617944
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:Atherosclerosis
 Carotid artery stenosis (CAS)
 cerebrovascular
 gut micriobiome
 ischemic stroke
K10plus-PPN:1757052739
Verknüpfungen:→ Zeitschrift
 
 
Lokale URL UB: Zum Volltext

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68733280   QR-Code
zum Seitenanfang